Miltefosine for visceral leishmaniasis.
Sherwood
J A
JA
D000284:Administration, Oral; D000634:Aminoquinolines / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000634:Aminoquinolines; D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine; C080436:8-aminoquinoline